Investigation of the influence of anti-glaucoma eyedrops on the ocular surface

Investigation of the influence of anti-glaucoma eyedrops on the ocular surface - The influence of anti-glaucoma eyedrops on the ocular surface

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030246

Enrollment

300

Registered

2017-12-08

Start date

2017-12-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Use of anti-glaucoma eyedrops over 3 months.

Exclusion criteria

Exclusion criteria: 1. Ocular surgery including laser therapy within 3 months. 2. History of corneal or conjunctival surgery. 3. History of glaucoma surgery. 4. History of surgery in thelacrimal drainage system. 5. History of contact lens use over 1 year. 6. Use of eyedrops other than anti-glaucoma eyedrops. 7. Existence of inflammatory disease in the anterior segment of the eye.

Design outcomes

Primary

Measure	Time frame
Score of corneal and conjunctival epithelial damage	—

Countries

Japan

Contacts

Public ContactShiro Amano

Inouye Eye Hospital Ophthalmology

amanoshiro1126@gmail.com03-3295-0925

Outcome results